Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-045981
Filing Date
2012-08-14
Accepted
2012-08-14 17:23:11
Documents
9
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v318843_10q.htm 10-Q 616717
2 EXHIBIT 31.1 v318843_ex31-1.htm EX-31.1 7515
3 EXHIBIT 32.1 v318843_ex32-1.htm EX-32.1 4049
  Complete submission text file 0001144204-12-045981.txt   4617785

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT xtls-20120630.xml EX-101.INS 523996
5 XBRL TAXONOMY EXTENSION SCHEMA xtls-20120630.xsd EX-101.SCH 39945
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xtls-20120630_cal.xml EX-101.CAL 50461
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xtls-20120630_def.xml EX-101.DEF 210484
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE xtls-20120630_lab.xml EX-101.LAB 378037
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xtls-20120630_pre.xml EX-101.PRE 269086
Mailing Address 630 FIFTH AVENUE SUITE 2260 NEW YORK NY 10020
Business Address 630 FIFTH AVENUE SUITE 2600 NEW YORK NY 10020 201-934-2000
Xstelos Holdings, Inc. (Filer) CIK: 0001540145 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 000-54646 | Film No.: 121034426
SIC: 2834 Pharmaceutical Preparations